Real-world evidence for coverage decisions: opportunities and challenges-Reference-Cited by-同舟云学术

Real-world evidence for coverage decisions: opportunities and challenges

Published:2018-12 Issue:12 Volume:7 Page:1133-1143
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:Journal of Comparative Effectiveness Research

Author:

Hampson Grace¹,Towse Adrian¹,Dreitlein William B²,Henshall Chris¹³,Pearson Steven D²

Affiliation:

1. Office of Health Economics, Southside, London, SW1E 6QT, UK

2. Institute for Clinical & Economic Review, Boston, MA, 02109, USA

3. Independent Consultant, UK

Abstract

Aim: To explore current uses of real-world evidence (RWE) in the US healthcare system, summarize key concerns and highlight various opportunities that could be realized through best use of RWE. Materials & methods: Information was gathered via a literature review and interviews to generate a background paper for the 2017 Institute for Clinical and Economic Review Policy Summit meeting. Results: RWE is currently being utilized in drug development decisions, regulatory approval decisions, post-approval monitoring, payer coverage decisions (initial decisions and reassessments) and for outcomes-based contracting. Solutions to key challenges and opportunities for future development are presented. Conclusion: Exciting opportunities for the use of RWE exist, yet important reservations remain. Solutions are within reach if effective partnerships between stakeholders can be nurtured.

Publisher

Future Medicine Ltd

Subject

Health Policy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cer-2018-0066

Reference30 articles.

1. Marchibroda J, Swope T, Watters S (2016). Bipartisan policy center. Using real-world-evidence to accelerate safe and effective cures: advancing medical innovation for a healthier America. https://bipartisanpolicy.org/wp-content/uploads/2016/06/BPC-Health-Innovation-Safe-Effective-Cures.pdf.

2. A Case Study of the New York City 2012-2013 Influenza Season With Daily Geocoded Twitter Data From Temporal and Spatiotemporal Perspectives

3. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts

4. Hampson G, Towse A, Dreitlein B, Henshall C, Pearson S. Real-world evidence for coverage decisions: opportunities and challenges – a report from the 2017 ICER Membership Policy Summit. Office of Health Economics, London, UK (2018).

5. A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases;Journal of Comparative Effectiveness Research;2024-09

2. Real‐world evidence to support regulatory submissions: A landscape review and assessment of use cases;Clinical and Translational Science;2024-08

3. Up-front matching: an ongoing recruitment method for prospective observational studies that mimics randomization for selected baseline covariates;Journal of Biopharmaceutical Statistics;2024-07-22

4. Uncertainty in Long-Term Relative Effectiveness of Medicines in Health Technology Assessment;Value in Health;2024-07

5. Cross-sectional analysis of use of real-world data in single technology appraisals of oncological medicine by the National Institute for Health and Care Excellence in 2011–2021;BMJ Open;2024-03